Taking Advantage of Viral Cytopathic Effects to Aid in the Rapid Screening of Effective Viral Therapies
Virology researchers use CPE effects pathogens elicit on the host to study host-pathogen interactions.
Demo on Demand: Modern Virology Assays Using Image Cytometry
Many leading labs in the field of virology have used the Celigo Image Cytometer to directly measure multiplex cell-based assays in real-time.
Demo on Demand: Modern Cell-based Assays for Cell and Gene Therapy Using Image Cytometry
Watch the demo on demand: Modern Cell-based Assays for Cell and Gene Therapy Using Image Cytometry
High-throughput Imaging Cytometry as a Powerful Tool for Drug Repurposing
Drug repurposing, also known as drug repositioning is a powerful tool for the rapid expansion of available therapy options by identifying new therapeutic uses from pre-existing drugs.
Simultaneously Image and Analyze Cell Expansion and Cytotoxic Potential During Ex Vivo Manufacturing
The microneutralization assay is a powerful, high-throughput screening tool crucial to the efficient development of novel vaccines and the discovery of compounds that can prevent or treat viral disease.
Science in the Time of COVID-19: Drug Repurposing
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
Webinar on Demand: A Modern Approach to Traditional Virology Research
During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.
Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Fight Against Coronavirus: Nexcelom China Team Provides Assay Development Support to Scientists
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Improving the viral plaque assay speed, sensitivity and robustness using imaging cytometry
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.